31st Annual Healthcare Conference

Keynote Speakers

The Marwood Group
Washington Insights: A Changing Environment

Tuesday, March 16, 2021
12:00-1:00 PM

As the nation continues to grapple with the ongoing COVID-19 crisis, the new Biden Administration, Congress, and states have been extremely active in moving policies designed to address the impacts on the healthcare system. With Congress trying to shape legislation addressing major industry priorities, we will be getting additional clarity on federal assistance to the healthcare system. Marwood’s senior Washington team will be available to address current and forthcoming legislative and regulatory COVID-19 responses, potential industry impact, and key upcoming catalysts.

Headshot	Speaker and Bio
	Speaker: Joseph Mercer, Director, Managed Care and Healthcare Services Mr. Mercer leads Marwood’s healthcare services and managed care practices. Prior to joining the Marwood Group, he served as a Program Analyst at the Center for Consumer Information and Insurance Oversight (CCIIO) division at CMS. From his tenure at CCIIO, Mr. Mercer brings with him substantial expertise covering government health insurance programs with a focus on ACA exchange and Medicare Advantage policy issues and catalysts. As a Program Analyst at CCIIO, some of his core responsibilities included tracking Federal and State legislative and regulatory changes, translating statutory and regulatory requirements into policy guidance, analyzing provisions of the Affordable Care Act for Federal and State regulators (as well as health insurers), serving as a health insurance issuer rating subject matter expert, and collaborating with other CCIIO groups and contractors with a primary focus on working with the Federally Facilitated Marketplace development and policy teams. Mr. Mercer holds a JD from Washington & Lee University School of Law and a BA in Economics from the College of William and Mary.
	Speaker: Steve Williams, PhD, Director, Life Sciences Dr. Williams leads Marwood’s life sciences team, which includes coverage of pharmaceuticals, biotechnology, clinical laboratories, PBMs, and medical devices. This includes focusing on analyzing regulatory issues related to the Food and Drug Administration (FDA) and other federal agencies responsible for regulating medical products. Prior to joining the Marwood Group, Dr. Williams was an investment banker focused on pharmaceutical and biotechnology companies, working with privately held and publicly traded companies to raise growth capital and develop business development strategies. Prior to that, he was an equity analyst covering the pharmaceutical and biotech industries, covering over a dozen U.S. and European companies. Before working in the financial sector, Dr. Williams was a biomedical researcher and held faculty positions at Vanderbilt University and Baylor College of Medicine. He holds a PhD in pharmacology from London University and an MBA from George Washington University.
	Speaker: Michael Gaffin, Senior Political Strategist Mr. Gaffin leads legislative outreach and analysis in Marwood Group’s Washington DC office, bringing a wealth of Capitol Hill experience to the firm. Prior, he served as the Legislative Director for the bipartisan US Senate Northeast Midwest Coalition, chaired by Senator Sherrod Brown (D-OH). Before his work in Senator Brown’s office, Mr. Gaffin served as Legislative Director for former Congressman Rob Andrews (D-NJ), one of the original authors of the Affordable Care Act. Mr. Gaffin also worked for Congresswoman Anna Eshoo (CA), Chairman George Miller’s Education and Labor Committee staff, and Senator Edward Kennedy’s HELP Committee staff.

Scott Gottlieb, M.D.
One Year Later: What Is the COVID -19 Endgame?

Wednesday, March 17, 2021
12:00-1:00 PM ET

As the nation continues to grapple with the ongoing COVID-19 crisis, the new Biden Administration, Congress, and states have been extremely active in moving policies designed to address the impacts on the healthcare system. With Congress trying to shape legislation addressing major industry priorities, we will be getting additional clarity on federal assistance to the healthcare system. Marwood’s senior Washington team will be available to address current and forthcoming legislative and regulatory COVID-19 responses, potential industry impact, and key upcoming catalysts.

Headshot

Speaker and Bio

Speaker: Scott Gottlieb. M.D. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.